Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The goals of this funding opportunity announcement (FOA) are to implement and rigorously evaluate SARS-CoV-2 rapid testing strategies in communities experiencing COVID-19 health disparities. These two-year Rapid Testing Research Projects will evaluate (1) rapid testing interventions to prevent and control COVID-19 transmission among underserved and vulnerable populations and (2) partnership-driven research to implement and evaluate rapid testing and reduce COVID-19 disparities. The funding for this program is provided from the American Rescue Plan Act of 2021, PL 117-2.

If interested in this opportunity, Duke investigators should contact:

Cinthia E. Sanchez, Ph.D. (cinthia.sanchez@duke.edu), CTSA Program Director, Duke Clinical & Translational Science Institute (CTSI) 

Deadline: May 2, 2022

RFA-OD-22-006 Expiration Date May 03, 2022

Agency Website

Amount Description

Application budgets are limited to $700,000 in direct costs per year and must reflect the actual needs of the proposed project.

The maximum period is 2 years.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 2, 2022